Johnson & Johnson
JNJ
|
News
|
$145.74
0.67%
-0.18%
7M
|
Health Technology
(0.0% 1d) (-6.8% 1m) (-11.4% 1y) (0.0% 2d) (0.1% 3d) (-2.2% 7d) (-100.0% volume)
Earnings Calendar: 2024-01-23
Market Cap: $ 351,201,782,290
http://www.jnj.com
Sec Filling | Patents | 132200 employees
(US) Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
vaccine cardiovascular eye infectious disease diabetes diabetic hypertension urea pulmonary hypertension women health immunology metabolic women
add to watch list Paper trade email alert is off
Press-releases
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
Published: 2024-04-19 (Just crawled : 12:00) - globenewswire.com
RPRX | $27.89 1.01% 0.99% 2.1M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
| Email alert
Add to watchlist
first pharma royalty financial results
FDA Requires Boxed Warning for Secondary Cancers on CAR-T Therapies
Published: 2024-04-19 (Just crawled : 12:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
| Email alert
Add to watchlist
fda for car-t
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Published: 2024-04-19 (Just crawled : 12:00) - biospace.com/
XOMA | News | $24.59 1.4% 2.84% 15K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
| Email alert
Add to watchlist
companies biopharma platform
Compass Diversified-Backed The Honey Pot Co. Strengthens Its Board With The Appointment of Three New Directors
Published: 2024-04-18 (Crawled : 13:00) - globenewswire.com
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
CODI | News | $22.33 0.86% -0.9% 190K
|
Finance
|
| O: 0.36%
H: 0.0%
C: 0.0%
pot honey
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Published: 2024-04-18 (Crawled : 13:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
XOMA | News | $24.59 1.4% 2.84% 15K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
companies biopharma platform
Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch
Published: 2024-04-18 (Crawled : 14:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
fda biosimilar approval for stelara
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Co...
Published: 2024-04-18 (Crawled : 18:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
XOMA | News | $24.59 1.4% 2.84% 15K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
biopharma platform
Health eCareers and AAPPR Expand Partnership to Advance Physician and Provider Recruitment and DE&I Efforts
Published: 2024-04-17 (Crawled : 21:00) - j2global.com
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
partnership health
Royalty Pharma Declares Second Quarter 2024 Dividend
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
RPRX | $27.89 1.01% 0.99% 2.1M
|
Health Technology
|
| O: -1.5%
H: 0.84%
C: 0.25%
pharma royalty
Prostate Cancer: Advancements in Prevention and Treatment Drive Global Market Growth
Published: 2024-04-17 (Crawled : 09:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.12%
H: 0.51%
C: 0.51%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
treatment global growth market
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 59% | 41% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
TPET | $0.3279 -3.56% 28.48% 33M
|
n/a
GDHG | $0.263 21.76% 25.34% 1.3M
|
HOLO | $2.95 31.7% 22.49% 37M
|
UMAC | $1.55 0.65% 16.13% 3K
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
VLD 4 | $0.2638 -3.65% 13.27% 2.6M
|
Manufacturing
ALLR | $1.54 2.67% 11.76% 740K
|
n/a
MGLD 4 | $1.13 5.61% 10.62% 200
|
Manufacturing
Last 48 Hours Insiders Buying
ADMQ | $0.0532 -4.14% -40.18% 480K
|
|
10:30
AXR P 2400 | $22.17 2.69% 0.0% 5.5K
|
Finance
|
21:00
QCRH P 118 | $55.41 1.34% 1.31% 54K
|
Finance
|
18:01
VUZI P 7500 | $1.26 3.28% 3.17% 930K
|
Electronic Technology
|
18:00
RMCF | $3.5501 0.57% 2.22% 18K
|
Consumer Non-Durables
|
20:10